Page 45 - 83_01

nitroimidazole drugs with DNA in vitro: structure-
activity relationships. Br J Cancer 1981; 44: 741-5.
193. Leitsch D, Kolarich D, Binder M, Stadlmann J,
Altmann F, Duchene M. Trichomonas vaginalis:
metronidazole and other nitroimidazole drugs are
reduced by the flavin enzyme thioredoxin reductase
and disrupt the cellular redox system. Implications for
nitroimidazole toxicity and resistance. Mol Microbiol
2009; 72: 518-36.
194. Land KM, Delgadillo-Correa MG, Tachezy J, et al.
Targeted gene replacement of a ferredoxin gene in
Trichomonas vaginalis does not lead to metronidazole
resistance. Mol Microbiol 2004; 51: 115-22.
195.? Pal D, Banerjee S, Cui J, Schwartz A, Ghosh SK,
Samuelson J. Giardia, Entamoeba, and Trichomonas
enzymes activate metronidazole (nitroreductases) and
inactivate metronidazole (nitroimidazole reductases).
Antimicrob Agents Chemother 2009; 53: 458-64.
196. Robinson SC. Trichomonal vaginitis resistant to
metranidazole. Can Med Assoc J 1962; 86: 665.
197. Meri T, Jokiranta TS, Suhonen L, Meri S. Resistance
of Trichomonas vaginalis to metronidazole: Report of
the first three cases from Finland and optimization of
in vitro susceptibility testing under various oxygen
concentrations. J Clin Microbiol 2000; 38: 763-7.
198. Pérez S, Fernández-Verdugo A, Pérez F, Vázquez F.
Prevalence of 5-nitroimidazole-resistant Trichomonas
vaginalis in Oviedo, Spain. Sex Transm Dis 2001; 28:
115-6.
199. Dunne RL, Dunn LA, Upcroft P, O'Donoghue PJ,
Upcroft JA. Drug resistance in the sexually
transmitted protozoan Trichomonas vaginalis. Cell
Res 2003; 13: 239-49.
200. Smith J, Garber GE. Current status and prospects for
development of a vaccine against Trichomonas
vaginalis infections. Vaccine 2014; 32: 1588-94.
201. Kulda J, Hrdy I. Hydrogenosome: The site of 5-
nitroimidazole activation and resistance. In: Tachezy
H, Ed. .Hydrogenosomes and mitosomes:
Mitochondria of anaerobic eukaryotes. Microbiology
Monographs. Springer 2008; pp. 179-200.
202. Rasoloson D, Tomkova E, Cammack R, Kulda J,
Tachezy J. Metronidazole-resistant strains of
Trichomonas vaginalis display increased
susceptibility to oxygen. Parasito 2001; 123: 45-56.
203. Schwebke JR, Barrientes FJ. Prevalence of
Trichomonas vaginalis isolates with resistance to
metronidazole and tinidazole. Antimicrob Agents
Chemother 2006; 50: 4209-10.
204. Kulda J, Tachezy J, Cerkasovova A. In vitro induced
anaerobic resistance to metronidazole in Trichomonas
vaginalis. J Eukaryot Microbiol 1993; 40: 262-9.
205. Sköld M, Gnarpe H, Hillstrom L. Ornidazole: a new
antiprotozoal compound for treatment of Trichomonas
vaginalis infection. Brit J Vener Dis 1977; 53: 44-8.
206. Singh PP, Jain A. Trichomoniasis: chemotherapy,
46
Alexandra Ibáñez-Escribano, Alicia Gómez-Barrio
drug-resistance and new targets. J Parasit Dis 2007;
31: 79-91.
207. Desrivot J, Waikedre J, Cabalion P, et al.
Antiparasitic activity of some New Caledonian
medicinal plants. J Ethnoparmacol 2007; 112: 7-12.
208. de Villiers BJ, van Vuuren SF, van Zyl RL, van Wyk
BE. Antimicrobial and antimalarial activity of
Cussonia species (Araliaceae). J Ethnopharm 2010;
129: 189-96.
209. Cheikh-Ali Z, Adiko M, Bouttier S, et al.
Composition, and antimicrobial and remarkable
antiprotozoal activities of the essential oil of rhizomes
of Aframomum sceptrum K.
Schum.(Zingiberaceae). Chem Biodivers 2011; 8:
658-67.
210. Calzada F, Yépez-Mulia L, Tapia-Contreras A. Effect
of Mexican medicinal plant used to treat
trichomoniasis on Trichomonas vaginalis
trophozoites. J Ethnopharmacol 2007; 113: 248-51.
211. Muelas-Serrano S, Nogal JJ, Martínez-Díaz RA,
Escario JA, Martínez-Fernández AR Gómez-Barrio A.
In vitro screening of American plant extracts on
Trypanosoma cruzi and Trichomonas vaginalis. J
Ethnopharm 2000; 71, 101-7.
212. Gómez-Barrio A, Martínez-Grueiro MM, Montero D,
et al. In vitro antiparasitic activity of plant extracts
from Panama. Pharm Biol 2004; 42: 332-7.
213. Frasson AP, dos Santos O, Duarte M, et al. First
report of anti-Trichomonas vaginalis activity of the
medicinal plant Polygala decumbens from the
Brazilian semi-arid region, Caatinga. Parasitol Res
2012; 110: 2581-7.
214. Brandelli, C.L.C., Vieira, P.D.B., Macedo, A.J.,
Tasca, T., 2013. Remarkable anti-Trichomonas
vaginalis activity of plants traditionally used by the
Mbya-Guarani indigenous group in Brazil. Biomed
Res Int 2013: 1-7.
215. Tasca Cargnin S, de Brum Vieira P, Cibulski S, et al.
Anti-Trichomonas vaginalis activity of Hypericum
polyanthemum extract obtained by supercritical fluid
extraction and isolated compounds. Parasitol Int 2013;
62: 112-7.
216. Vital PG, Rivera WL. Antimicrobial activity,
cytotoxicity, and phytochemical screening of
Voacanga globosa (Blanco) Merr. leaf extract
(Apocynaceae). Asian Pacific J Trop Med 2011; 4:
824-8.
217. Ertabaklar H, Kivcak B, Mert T, TÖZ SÖ. In vitro
activity of Arbutus unedo leaf extracts against
Trichomonas vaginalis trophozoites. Türkiye Parazitol
Derg 2009; 33: 263-4.
218. Martin T, Villaescusa L, Gasquet M, et al. Screening
for protozoocidal activity of Spanish plants. Pharm
Biol 1998; 36: 56-62.
219. Martínez-Díaz RA, Ibáñez-Escribano A, Burillo J, et
al. Trypanocidal, trichomonacidal and cytotoxic
components of cultivated Artemisia absinthium
@Real Academia Nacional de Farmacia. Spain